| ACh | acetylcholine |
| AChE | acetylcholinesterase |
| ASDIN | active-site-directed inhibitor |
| BChE | butyrylcholinesterase |
| AChEIs | acetylcholinesterase inhibitor |
| AD | Alzheimer’s disease |
| ChE | cholinesterase |
| COMT | catechol-O-methyltransferase |
| DA | dopamine |
| DFP | diisopropylfluoro phosphate (diisopropylphosphofluoridate) |
| L-DOPA | L-3,4-dihydroxyphenylalanine (dopamine precursor) |
| DTNB | 5,5’-dithio-bis-[2-nitrobenzoic acid] |
| FAD | flavin adenine dinucleotide |
| 5-HT | 5-hydroxytryptamine (serotonin) |
| MAO | monoamine oxidase |
| MAOI | monoamine oxidase inhibitor |
| MTDL | multitarget-directed ligand |
| NTE | neuropathy-target esterase |
| OP | organophosphate |
| PAS | peripheral anionic site |
| PD | Parkinson’s disease |
| PS | presenilin |
| QSAR | quantitative structure-activity relationship |
| TNB | 2-nitro-5-thiobenzoate |